Studies by Rosario et al. and De Nunzio et al. both found that a second PSA measurement showing a reduction greater than 20% was associated with a lower likelihood of detecting prostate cancer or csPCa on biopsy [8,10]. Here, KLK3 is linked to prostate carcinoma.